Report Description

India sulfadiazine market is expected to grow at a steady rate during the forecast period. The India sulfadiazine market is driven by the widespread use of the drug along with pyrimethamine for the treatment of toxoplasmosis. Additionally, the drug is used in the treatment of rheumatoid fever, chlamydia, among others. Furthermore, the drug is present in the WHO’s list of essential medications. This in turn is expected to positively influence the market growth through FY2026.

The India sulfadiazine market is segmented based on product type, route of administration, source, form, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, topical and intravenous. The oral route is expected to dominate the market since when the drug is consumed orally the absorption takes place along the complete line of GI tract. The intravenous route is expected to grow significantly since this route of administration has 100% bioavailability and provides desired blood concentrations in the human body.

The major players operating in the India sulfadiazine market are Abbott India Ltd., Boehringer Ingelheim India Private Ltd., Novartis India Ltd., Emcure Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Anuh Pharma Ltd., Anuja Healthcare Ltd., Salvi Chemical Industries Ltd., Centurion Laboratories Private Ltd., Pfizer Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, portfolio enhancement and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India sulfadiazine market from FY2016 to FY2019.
  • To estimate and forecast the market size of India sulfadiazine market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India sulfadiazine market based on product type, route of administration, source, form, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India sulfadiazine market.
  • To identify drivers and challenges for India sulfadiazine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India sulfadiazine market.
  • To identify and analyze the profile of leading players operating in India sulfadiazine market.
  • To identify key sustainable strategies adopted by market players in India sulfadiazine market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India sulfadiazine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Sulfadiazine manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to sulfadiazine

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India sulfadiazine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Sulfadiazine Market, By Product Type:
    • OTC
    • Prescription
  • India Sulfadiazine Market, By Route of Administration:
    • Oral
    • Topical
    • Intravenous
  • India Sulfadiazine Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Sulfadiazine Market, By Form:
    • Tablet
    • Capsule
    • Cream
    • Injection
    • Others
  • India Sulfadiazine Market, By Distribution Channel:
    • Online
    • Offline
  • India Sulfadiazine Market, By Application:
    • Urinary Tract Infections
    • Ear Infections
    • Meningitis
    • Malaria
    • Toxoplasmosis
    • Others
  • India Sulfadiazine Market, By End User:
    • Adult
    • Pediatric (more than 2 months)
  • India Sulfadiazine Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India sulfadiazine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India Sulfadiazine market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Sulfadiazine Market

4.    Executive Summary

5.    Manufacturing Sulfadiazine

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Sulfadiazine

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Sulfadiazine Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type (OTC v/s Prescription)

7.2.2.     By Route of Administration (Oral, Topical, Intravenous)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Form (Tablet, Capsule, Cream, Injection, Others)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Urinary Tract Infections, Ear Infections, Meningitis, Malaria, Toxoplasmosis, Others)

7.2.7.     By End User (Adult v/s Pediatric (more than 2 months))

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Abbott India Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Boehringer Ingelheim India Private Ltd.

14.1.3.  Novartis India Ltd.

14.1.4.  Emcure Pharmaceuticals Ltd.

14.1.5.  Sun Pharmaceuticals Industries Ltd.

14.1.6.  Anuh Pharma Ltd.

14.1.7.  Anuja Healthcare Ltd.

14.1.8.  Salvi Chemical Industries Ltd.

14.1.9.  Centurion Laboratories Private Ltd.

14.1.10.                Pfizer Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

Figures and Tables

Frequently asked questions